Practical Aspects of Pharmacogenomics Implementation

Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:

• Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
• Andrew Monte, MD, PhD (University of Colorado)
  
• Trina Walker, DNP, APRN, FNP-C (Creighton University)
• Nguyen Park, MS, PA-C (National Human Genome Research Institute)
• Jeneva Gularte-Rinaldo, PhD, RN (Samuel Merritt University)

Course Directors

	Otito Frances Iwuchukwu, PhD, MA Associate Professor Fairleigh Dickinson University
	Jenny Nguyen, PharmD, APh, BCPS Clinical Pharmacogenomics Specialist Children's Hospital Los Angeles

Additional Content Reviewers

• Natasha Petry, PharmD, BCACP, Associate Professor, North Dakota State University and Sanford Health Imagenetics
• Vivian K. Kawai MD, MPH, Director of Pharmacogenomics, Vanderbilt University School of Medicine
  

All healthcare professionals

LEARNING OBJECTIVES

• Describe the components and practical aspects of standard pharmacogenomics implementation.
  
• Identify the roles of various healthcare professionals in implementation teams.
• Evaluate curated examples of successful implementation programs in different practice settings.
• Apply model principles of pharmacogenomics implementation using a familiar and readily implementable gene-drug or gene-disease pair case example for a clinical practice (or system).